Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jul 16, 2018 $136.27 $136.87 $133.80 $134.58 1 132 168
Jul 13, 2018 $134.48 $136.47 $134.00 $135.87 1 574 398
Jul 12, 2018 $131.77 $134.33 $131.50 $134.29 1 618 371
Jul 11, 2018 $131.11 $131.79 $129.71 $131.12 825 278
Jul 10, 2018 $131.64 $132.03 $130.45 $131.91 894 809
Jul 09, 2018 $132.93 $132.99 $129.81 $131.58 1 480 780
Jul 06, 2018 $129.10 $132.48 $128.27 $132.20 1 464 468
Jul 05, 2018 $126.83 $128.74 $125.51 $128.08 1 099 215
Jul 03, 2018 $126.46 $126.79 $124.56 $125.76 619 312
Jul 02, 2018 $124.17 $125.22 $122.00 $125.00 1 295 014
Jun 29, 2018 $122.48 $125.25 $121.91 $124.15 1 095 553
Jun 28, 2018 $121.80 $123.58 $119.57 $121.66 1 335 092
Jun 27, 2018 $122.67 $124.28 $120.69 $121.84 1 189 004
Jun 26, 2018 $125.05 $125.90 $121.87 $122.43 1 227 037
Jun 25, 2018 $126.89 $127.14 $123.67 $124.83 1 427 884
Jun 22, 2018 $125.71 $128.64 $125.37 $127.57 2 326 965
Jun 21, 2018 $124.15 $126.14 $123.86 $125.81 1 495 960
Jun 20, 2018 $122.39 $124.77 $121.86 $124.52 1 044 112
Jun 19, 2018 $117.72 $122.50 $117.72 $121.91 1 208 928
Jun 18, 2018 $120.05 $120.50 $117.30 $118.67 1 281 408
Jun 15, 2018 $120.00 $121.85 $118.99 $121.52 2 212 231
Jun 14, 2018 $118.83 $120.54 $118.26 $120.16 1 029 966
Jun 13, 2018 $117.58 $119.85 $117.16 $118.20 1 143 997
Jun 12, 2018 $116.45 $118.59 $115.67 $117.58 1 338 749
Jun 11, 2018 $118.12 $118.31 $116.08 $116.70 853 621
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT